CEE ENDOCONNECT meeting
CEE ENDOCONNECT meeting 11–12 May 2015 Prague, Czech Republic Agenda Monday 11th May – afternoon 1345 1400 1410 Welcome and introduction Welcome from the host country Genetic heritage of hypopituitarism in Central and Eastern Europe Symposium 1 – GH therapy during transition and beyond 1440 Why continue GH? 1510 Who, how and when to test for permanent GH deficiency? 1540 How to treat GH deficiency during transition and in adulthood 1610 Coffee Symposium 2 – Long-term safety review of GH treatment 1630 Introduction to the symposium 1645 Outputs from the ESPE/PES/GRS 2015 consensus summary: • Paediatric perspective • Adult perspective 1745 1815 Panel discussion Close EBT/GEN/15/06-c Date of preparation: March 2015 Roy Gomez Michal Krsek Jan Lebl Chair: Jan Lebl Anton Luger Mohamed Maghnie Fahrettin Kelestimur Chair: Moshe Philip Moshe Philip Lars Savendahl 1st: Gudmundur Johansson 2nd: Richard Ross 3rd: Jens Christiansen 4th: Eva Marie Erfruth Moshe Philip Tuesday 12th May – morning 0830 Welcome to day 2 Symposium 3 – Turner Syndrome from childhood to adulthood 0840 Paediatric perspective 0900 Adult perspective 0920 Panel discussion Paediatric endocrinology stream Chair: Feyza Darendeliler Catch-up growth Physiology of 0930 Jan Maarten Wit catch-up 0950 Nutrition Moshe Phillip 1010 Catch-up with GH Michael Ranke 1030 Coffee Feyza Case-based 1050 Darendeliler, Jan discussion Lebl 1st: Martin Savage Optimising GH 2nd: Anita Hokken therapy in Koelega 1220 paediatric age 3rd: Maithe group Tauber 1250 Growth prediction models 1330 Lunch Michael Ranke Tuesday 12th May – afternoon 0930 1000 Adult endocrinology stream Chair: Michael Buchfelder Historical perspectives on Wouter de Herder acromegaly Recent advances in Michael pituitary surgery Buchfelder 1050 Case-based discussion Vera Popovic, Martha Korbonits 1220 What does treatment success look like? Felipe Casanueva 1250 Multidisciplinary approach to management of acromegaly Vaclav Hana Symposium 4 – Gigantism and acromegaly 1430 Latest understanding of aetiology and pathogenesis 1500 A review of the recent treatment guidelines for acromegaly 1530 Long-term follow-up 1600 Closing remarks EBT/GEN/15/06-c Date of preparation: March 2015 Chair: Jan Maarten Wit Feyza Darendeliler 1st: Claus Gravholt 2nd: Gerry Conway Chair: Miklos Goth Marta Korbonits Vera Popovic Marija Pfeifer TBD
© Copyright 2024